Botulinum Toxin Market Size, Share & Trends Analysis Report By Product Type (Type A, Type B), By Application (Therapeutic, Aesthetic), By End Use, By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 100 pages | ID: B17F1BC541BEN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 3 Business Days

Botulinum Toxin Market Growth & Trends

The global botulinum toxin market size is expected to reach USD 15.4 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 11.5% from 2022 to 2030. Botulinum toxin is a drug formed from a toxin built by the bacteria clostridium botulinum. These drugs work by paralyzing or tempering specific muscles or by hindering certain nerves. The effect of the drug lasts for about a few months, depending on the treatment. Botulinum toxin is used for both therapeutic and aesthetic applications. Nowadays, the drug is highly adopted for aesthetic procedures. For instance, Botox is a non-invasive cosmetic procedure and is used to reduce forehead creases, facial fine lines, wrinkles, and crow’s feet among others. The demand for botulinum toxin is expected to grow during the forecast period owing to the growing demand for minimally invasive or non-invasive procedures in aesthetics. Furthermore, increasing application in therapeutic applications, coupled with growing R&D initiatives, is e

xpected to expand the market.

Population aged above 40 years are focusing on the physical features and wish to have a younger look. Thus, rising emphasis on aesthetic beauty, for instance, lip treatments by women, especially in developed countries is anticipated to fuel the industry growth. Also, botulinum toxin is used to treat several age-related conditions such as glabellar lines, crow’s feet, and forehead lines. Hence, people above the age of 40 are more vulnerable to such signs of aging. Therefore, procedures of botulinum toxin are gaining more popularity among individuals aged between 40-55 years, thereby augmenting the industry growth. Furthermore, rising cases of chronic disorders such as migraine and cervical dystonia are likely to drive the market.

The COVID-19 outbreak has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many aesthetic treatments and procedures were halted. The COVID-19 pandemic has caused a huge disruption in the supply chain of the overall medical industry. However, the sales of botulinum toxins such as botox observed a surge due to the increased demand during the pandemic. Several plastic surgeons and dermatologists are accrediting the boom to individuals wishing to put their finest appearance for online meetings and conferences and greater time to attend consultations and recover from procedures.

Botulinum Toxin Market Report Highlights

• The type A product type segment dominated the market in 2021. This is because type A products including Dysport and Botox are commercially available in the market in most countries and have been clinically tested and proven to be safe and effective in the long term with minimal side effects
• The aesthetic application segment is expected to register a significant CAGR of 12.2% during the forecast period. Growing concerns over cosmetic features in developed and developing countries have led to a rise in the number of aesthetic procedures
• North America dominated the global market in 2021 with a revenue share of over 35.0% owing to the rising technological advancements for cosmetic treatments and the increasing number of specialists and service providers
• Asia Pacific is expected to register the highest CAGR over the forecast period owing to the growing patient population, rising awareness regarding aesthetic procedures, and rapid technological advancements

Contents

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Product Type
  1.1.2 Application
  1.1.3 End-Use
  1.1.4 Regional Scope
  1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased Database
  1.3.2 Gvr’s Internal Database
  1.3.3 Secondary Sources
  1.3.4 Primary Research
  1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective - 1:
  1.10.2 Objective - 2:
  1.10.3 Objective - 3:
  1.10.4 Objective - 4:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook

CHAPTER 3 BOTULINUM TOXIN MARKET: VARIABLES, TRENDS, & SCOPE

3.1 Market Segmentation and Scope
3.2 Market Dynamics
  3.2.1 Market Driver Analysis
    3.2.2.1 Increasing Number Of Patients Having Neurological Disorders
    3.2.2.2 Rising Preference For Non-Invasive Or Minimally Invasive Procedures
    3.2.2.3 Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate
  3.2.2 Market Restraint Analysis
    3.2.2.1 High cost of cosmetic procedure
3.3 Penetration & Growth Prospect Mapping
3.4 Botulinum Toxin: Market Analysis Tools
  3.4.1 Industry Analysis - Porter’s
  3.4.2 Pestel Analysis

CHAPTER 4 BOTULINUM TOXIN MARKET: PRODUCT TYPE SEGMENT ANALYSIS

4.1 Botulinum Toxin: Product type Market Share Analysis, 2021 & 2030
4.2 Type A
  4.2.1 Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3 Type B
  4.3.1 Type B Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

CHAPTER 5 BOTULINUM TOXIN MARKET: APPLICATION SEGMENT ANALYSIS

5.1 Botulinum Toxin: Application Market Share Analysis, 2021 & 2030
5.2 Therapeutic
  5.2.1 Therapeutic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.3 Aesthetic
  5.3.1 Aesthetic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

CHAPTER 6 BOTULINUM TOXIN MARKET: END-USE SEGMENT ANALYSIS

6.1 Botulinum Toxin: End-use Market Share Analysis, 2021 & 2030
6.2 Hospitals
  6.2.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.3 Dermatology Clinics
  6.3.1 Dermatology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.4 Spas and Cosmetic Centers
  6.4.1 Spas and Cosmetic Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

CHAPTER 7 BOTULINUM TOXIN MARKET: REGIONAL ANALYSIS

7.1 Botulinum Toxin: Regional Market Share Analysis, 2021 & 2030
7.2 North America
  7.2.1 North America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.2.2 U.S.
    7.2.2.1 U.S. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.2.3 Canada
    7.2.3.1 Canada Botulinum Toxin Market, 2018 - 2030(USD Billion)
7.3 Europe
  7.3.1 Europe Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.3.2 U.K.
    7.3.2.1 U.K. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.3.3 Germany
    7.3.3.1 Germany Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.3.4 France
    7.3.4.1 France Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.3.5 Italy
    7.3.5.1 Italy Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.3.6 Spain
    7.3.6.1 Spain Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4 Asia Pacific
  7.4.1 Asia Pacific Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.4.2 China
    7.4.2.1 China Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.4.3 India
    7.4.3.1 India Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.4.4 Japan
    7.4.4.1 Japan Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.4.5 South Korea
    7.4.5.1 South Korea Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.4.6 Australia
    7.4.6.1 Australia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.5 Latin America
  7.5.1 Latin America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.5.2 Brazil
    7.5.2.1 Brazil Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.5.3 Mexico
    7.5.3.1 Mexico Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.5.4 Argentina
    7.5.4.1 Argentina Botulinum Toxin Market,2018 - 2030 (USD Billion)
7.6 MEA
  7.6.1 MEA Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.6.2 South Africa
    7.6.2.1 South Africa Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.6.3 Saudi Arabia
    7.6.3.1 Saudi Arabia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  7.6.4 UAE
    7.6.4.1 UAE Botulinum Toxin Market, 2018 - 2030 (USD Billion)

CHAPTER 8 COMPANY PROFILES

8.1 IPSEN GROUP
  8.1.1 Company overview
  8.1.2 Financial performance
  8.1.3 Product benchmarking
  8.1.4 Strategic initiatives
8.2 ALLERGEN INC.
  8.2.1 Company overview
  8.2.2 Financial performance
  8.2.3 Product Benchmarking
  8.2.4 Strategic initiatives
8.3 MEDY-TOX, INC.
  8.3.1 Company overview
  8.3.2 Financial performance
  8.3.3 Product benchmarking
  8.3.4 Strategic initiatives
8.4 METABIOLOGICS
  8.4.1 Company overview
  8.4.2 Financial performance
  8.4.3 Strategic initiatives
8.5 MERZ PHARMA
  8.5.1 Company overview
  8.5.2 Financial performance
  8.5.3 Product benchmarking
  8.5.4 Strategic initiatives
8.6 US WORLDMEDS
  8.6.1 Company overview
  8.6.2 Financial performance
  8.6.3 Product benchmarking
  8.6.4 Strategic initiatives
8.7 EVOLUS
  8.7.1 Company overview
  8.7.2 Financial performance
  8.7.3 Product benchmarking
  8.7.4 Strategic initiatives
8.8 GALDERMA
  8.8.1 Company overview
  8.8.2 Financial performance
  8.8.3 Product benchmarking
  8.8.4 Strategic initiatives
8.9 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS
  8.9.1 Company overview
  8.9.2 Financial performance
  8.9.3 Product benchmarking
  8.9.4 Strategic initiatives

List Of Tables

LIST OF TABLES

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Strategic collaborations by key players

List Of Figures

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Botulinum Toxin Market snapshot (2021)
Fig. 10 Botulinum Toxin Market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Botulinum toxin market product type outlook: Segment dashboard
Fig. 17 Botulinum toxin market: product type movement analysis
Fig. 18 Type A market, 2018 - 2030 (USD Billion)
Fig. 19 Type B market, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum toxin market application outlook: Segment dashboard
Fig. 21 Botulinum Toxin Market: Application movement analysis
Fig. 22 Therapeutic market, 2018 - 2030 (USD Billion)
Fig. 23 Aesthetic market, 2018 - 2030 (USD Billion)
Fig. 24 Botulinum toxin market end-use outlook: Segment dashboard
Fig. 25 Botulinum Toxin Market: End-use movement analysis
Fig. 26 Hopsitals market, 2018 - 2030 (USD Billion)
Fig. 27 Dermatology clinics market, 2018 - 2030 (USD Billion)
Fig. 28 Spas and cosmetic centersmarket, 2018 - 2030 (USD Billion)
Fig. 29 Regional market: Key takeaways
Fig. 30 Regional outlook: 2021& 2030
Fig. 31 North America market, 2018 - 2030 (USD Billion)
Fig. 32 U.S. market, 2018 - 2030 (USD Billion)
Fig. 33 Canada market, 2018 - 2030 (USD Billion)
Fig. 34 Europe market, 2018 - 2030
Fig. 35 U.K. market, 2018 - 2030 (USD Billion)
Fig. 36 Germany market, 2018 - 2030 (USD Billion)
Fig. 37 France market, 2018 - 2030 (USD Billion)
Fig. 38 Italy market,2018 - 2030 (USD Billion)
Fig. 39 Spain market, 2018 - 2030 (USD Billion)
Fig. 40 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 41 China market, 2018 - 2030 (USD Billion)
Fig. 42 Japan market, 2018 - 2030 (USD Billion)
Fig. 43 India market, 2018 - 2030 (USD Billion)
Fig. 44 South Korea market, 2018 - 2030 (USD Billion
Fig. 45 Australia market, 2018 - 2030 (USD Billion
Fig. 46 Latin America market, 2018 - 2030 (USD Billion)
Fig. 47 Brazil market, 2018 - 2030 (USD Billion)
Fig. 48 Mexico market, 2018 - 2030 (USD Billion)
Fig. 49 Argentina market, 2018 - 2030 (USD Billion)
Fig. 50 MEA market, 2018 - 2030 (USD Billion)
Fig. 51 South Africa market, 2018 - 2030 (USD Billion)
Fig. 52 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 53 UAE market, 2018 - 2030 (USD Billion)